Harrow Health, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in San Diego, California and currently employs 134 full-time employees. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.